Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley

Saudi Journal of Gastroenterology

Volumn 17, Issue 5, 2011, Pages 301-306

  Malik, Manzoor ^a   Sharma, Kiran ^a   Zargar, Showket ^b   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Esophageal cancer; Kashmir valley; MMP 7 (181A>G) polymorphism

Indexed keywords

MATRILYSIN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DNA POLYMORPHISM; DOMINANT INHERITANCE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOOD INTAKE; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECESSIVE INHERITANCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TEA;

ALLELES; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; INDIA; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 80052889270     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.84480     Document Type: Article

References (43)

1. Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol 2008;13:102-11. (Pubitemid 351668181)
2. Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 1992;33:11-5.
3. Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, Preussmann R. Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis 1992;13:1331-5.
4. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer 2009a;40:26-32.
5. Malik MA, Upadhyay R, Modi DR, Zargar SA, Mittal B. Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley. Arch Med Res 2009b;40:416-23.
6. Brown PD. Matrix metalloproteinases in gastrointestinal cancer. Gut 1998;43:161-3. (Pubitemid 28348313)
7. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Noboru N, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymatic properties. J Biol Chem 1995;270:6691-7.
8. Murphy G, Cocket M, Ward R, Docherty AJ. Matrix metalloproteinase degradation of elastin, type IV collagen, and proteoglycan: A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysin-1 and 2 and punctuated metalloproteinase (PUMP). Biochem J 1991;277:277-9.
9. Sires UI, Griffin GL, Broekelmann TJ, Mecham RP, Murphy G, Chung AE, et al. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J Biol Chem 1993;268:2069-74. (Pubitemid 23033615)
10. Crabbe T, Smith B, O'Connell J, Docherty A. Human progelatinase A can be activated by matrilysin. FEBS Lett 1994;345:14-6.
11. Sang QA, Bodden MK, Windsor LJ. Activation of human progelatinase A by collagenase and matrilysin: Activation of procollagenase by matrilysin. J Protein Chem 1996;15:243-53. (Pubitemid 126735408)
12. Sires UI, Murphy G, Baragi VM, Fliszar C, Welgus HG, Senior RM. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of a1-antitrypsin. Biochem Biophys Res Commun 1994;204:613-20. (Pubitemid 24343964)
13. Jones LE, Humphreys MJ, Campbell F, Neoptolemos JP, Boyd MT. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: Increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 2004;10:2832-45. (Pubitemid 38509163)
14. Jormsj S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P. Allelespecific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2001;21:1834-9.
15. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 1998;185:256-61.
16. Etoh T, Inoue H, Yoshikawa Y, Barnard GF, Kitano S, Mori M. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut 2000;47:50-6. (Pubitemid 30430411)
17. Zhang J, Jin X, fang S, Wang R, Li Y, Wang N, et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 2005;26:1748-53. (Pubitemid 41487990)
18. Yeh YC, Sheu BS, Cheng HC, Wang YL, Yang HB, Wu JJ. Elevated serum matrix metalloproteinase-3 and 7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival. Dig Dis Sci 2010;55:1649-57.
19. Peng B, Cao L, Ma X, Wang W, Wang D, Yu L. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis 2010;25:371-9.
20. Hellmig S, Ott S, Rosenstiel P, Robert UF, Hampe J, Schreiber S. Genetic variants in matrixmetalloproteinase genes are associated with development of gastric ulcer in H. pylori infection. Am J Gastroenterol 2006;101:29-35. (Pubitemid 43381705)
21. Vairaktaris E, Serefoglou Z, Yapijakis C, Vylliotis A, Nkenke E, Derka S, et al. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. Anticancer Res 2007;27:2493-8. (Pubitemid 47228094)
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
23. Bjorklund M, Koivunen E. Gelatinasemediated migration and invasion of cancer cells. Biochim Biophys Acta 2005;1755:37-69. (Pubitemid 40720240)
24. Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K. Clinical significance of matrix metalloproteinase-7 in esophageal carcinoma. Clin Cancer Res 2000;6:1169-74. (Pubitemid 30159381)
25. Li Y, Jin X, Kang S, Wang Y, Du H, Zhang J, et al. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and 9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol 2006;101:92-6.
26. Ghilardi G, Biondi ML, Erario M, Guagnellini E, Scorza1 R. Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem 2003;49:1940-2. (Pubitemid 37340333)
27. Singh H, Jain M, Mittal B. MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer. Gynecol Oncol. 2008;110:71-5.
28. Srivastava P, Gangwar R, Kapoor R, Mittal RD. Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Dis Markers. 2010;29:37-46.
29. Beeghly-Fadiel A, Shu XO, Long J, Li C, Cai Q, Cai H, et al. Genetic polymorphisms in the MMP-7 gene and breast cancer survival. Int J Cancer 2009;124:208-14.
30. Livre A, Milet J, Carayol J, Le Corre D, Milan C, Pariente A, et al. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer 2006;6:270.
31. Beeghly-Fadiel A, Long JR, Gao YT, Li C, Qu S, Cai Q, et al. Common MMP-7 polymorphisms and breast cancer susceptibility: A multistage study of association and functionality. Cancer Res 2008;68:6453-9.
32. Dos Reis ST, Pontes J Jr, Villanova FE, Borra PM, Antunes AA, Dall'oglio MF, et al. Genetic polymorphisms of matrix metalloproteinases: Susceptibility and prognostic implications for prostate cancer. J Urol 2009;181:2320-5.
33. Wu SH, Zhang J, Li Y, Li JM. Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis. Ai Zheng 2006;25:315-9.
34. Yu WH, Woessner JF, McNeish JD, Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002;16:307-23. (Pubitemid 34111411)
35. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001;114:111-8. (Pubitemid 32120080)
36. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999;9:1441-7. (Pubitemid 30023478)
37. Gumbiner BM. Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-57. (Pubitemid 26058560)
38. Vargo-Gogola T, Fingleton B, Crawford HC, Matrisian LM. Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Cancer Res 2002;62:5559-63.
39. Barille S, Bataille R, Rapp MJ, Harousseau JL, Amiot M. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J Immunol 1999;163:5723-8.
40. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74. (Pubitemid 37328786)
41. Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y, et al. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 2005;100:1835-43. (Pubitemid 41648441)
42. Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. High-temperature beverages and foods and esophageal cancer risk - a systematic review. Int J Cancer 2009;125:491-524.
43. Correa P. Modulation of gastric carcinogenesis: Updated model based on intragastric nitrosation. IARC Sci Publ 1987;84:485-91.